Pharmstandard - Strategic SWOT Analysis Review

Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Report Scope

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - The analyst’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Pharmstandard develops, manufactures, and distributes a range of pharmaceutical products. The company offers prescription pharmaceuticals and over-the-counter (OTC) drugs. It also provides contract manufacturing services. Pharmstandard manufactures medicines of various pharmacotherapeutic groups, including those for treatments of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological and infectious diseases, neurological disorders, metabolic disorders, oncology and a variety of other diseases. Pharmstandard’s product portfolio includes drugs for treatment of cardiovascular diseases, gastroenterology diseases, contagious diseases, cancer, neurology diseases, diabetes, growth hormone deficiency, metabolic disorders and other diseases. The company serves customers in the Commonwealth of Independent States and Former Soviet Union countries. Pharmstandard is headquartered in Dolgoprudny, Moscow, Russia.

Pharmstandard Key Recent Developments

• Jun 02, 2025: Dmitry Zaitsev: Pharma Industry Patents Require Special Attention of the State
• May 30, 2025: GxP-Fest Partners Shared their Participation and Cooperation Impressions
• May 30, 2025: LEKKO CJSC Will Channel RUB 1.5 bln. to Expand Production
• May 19, 2025: Pharmstandard Group: EPS Rating Is our Development Benchmark

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.